Apeiron Ria LLC Thermo Fisher Scientific Inc. Transaction History

Apeiron Ria LLC

$343 Million
Q3 2024

A detailed history of Apeiron Ria LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Apeiron Ria LLC holds 768 shares of TMO stock, worth $394,905. This represents 0.14% of its overall portfolio holdings.

Number of Shares

768

Previous 757 1.45%

Holding current value

$394,905

Previous $418,000 13.64%

% of portfolio

0.14%

Previous 0.13%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$531.86 - $624.21 $5,850 - $6,866	11 Added 1.45%	768 $475,000
Q2 2024 Jul 16, 2024	SELL	$541.52 - $599.02 $8,122 - $8,985	-15 Reduced 1.94%	757 $418,000
Q1 2024 Apr 15, 2024	SELL	$528.82 - $599.43 $3,172 - $3,596	-6 Reduced 0.77%	772 $448,000
Q4 2023 Jan 12, 2024	BUY	$431.41 - $532.94 $46,160 - $57,024	107 Added 15.95%	778 $412,000
Q3 2023 Oct 19, 2023	BUY	$498.29 - $574.41 $15,446 - $17,806	31 Added 4.84%	671 $339,000
Q2 2023 Jul 20, 2023	SELL	$508.46 - $591.13 $11,694 - $13,595	-23 Reduced 3.47%	640 $333,000
Q1 2023 Apr 13, 2023	BUY	$535.0 - $604.82 $8,025 - $9,072	15 Added 2.31%	663 $382,000
Q4 2022 Jan 20, 2023	BUY	$484.71 - $571.37 $3,392 - $3,999	7 Added 1.09%	648 $0
Q3 2022 Oct 18, 2022	BUY	$507.19 - $604.49 $325,108 - $387,478	641 New	641 $321,000
Q2 2022 Jul 26, 2022	SELL	$500.9 - $612.21 $258,464 - $315,900	-516 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$524.0 - $644.92 $21,484 - $26,441	41 Added 8.63%	516 $316,000
Q4 2021 Feb 15, 2022	BUY	$569.0 - $667.24 $270,275 - $316,939	475 New	475 $317,000

Others Institutions Holding TMO

# of Institutions

2,832

Shares Held

334M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $201B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apeiron Ria LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apeiron Ria LLC with notifications on news.

Account